Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
A2585 MG-132124 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A4002 IU11 CitationSummary: Usp14 inhibitor -
A1903 E 64d8 CitationSummary: Cysteine protease inhibitor -
A8212 PR-619Target: Deubiquitinating enzymes (DUBs)Summary: Deubiquitylating enzymes (DBUs) inhibitor -
A8487 Nocodazole7 CitationTarget: Microtubules/TubulinsSummary: microtubule polymerization inhibitor -
A8627 Bafilomycin A131 CitationSummary: V-ATPases inhibitor -
A2571 Pepstatin A9 CitationTarget: Cathepsins|Renin|HIV proteases|PepsinsSummary: aspartic proteases inhibitor -
B7745 SZL P1-41Summary: Skp2 inhibitor -
A2614 Bortezomib (PS-341)51 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A4393 Paclitaxel (Taxol)27 CitationTarget: Microtubules/TubulinsSummary: microtubule depolymerization inhibitor

